FDA Delays AERS Upgrade; New Maintenance Contract Goes To SAIC
Executive Summary
FDA is working on approaches to obtain funding for a planned upgrade to the Adverse Event Reporting System
You may also be interested in...
FDA Unveils Rx Safety Board, Website; Postmarket Surveillance Overhaul Next
HHS is planning a major overhaul of FDA's postmarketing surveillance system as the centerpiece of its next announcement about upgrades to the drug safety regulatory system
FDA Unveils Rx Safety Board, Website; Postmarket Surveillance Overhaul Next
HHS is planning a major overhaul of FDA's postmarketing surveillance system as the centerpiece of its next announcement about upgrades to the drug safety regulatory system
FDA Drug Safety Website Under Development As One Response To Concerns
FDA is understood to be developing a drug safety website as part of an initiative to address concerns about post-marketing surveillance